Seven days of bismuth-based quadruple therapy is as effective for the first-line treatment of clarithromycin-resistant confirmed helicobacter pylori infection as 14 days of bismuth-based quadruple therapy

HIGHLIGHTS

• who: Sang-Gon Moon and collaborators from the Division of Gastroenterology, Department of Internal Medicine, Eunpyeong StMary's Hospital, Department of Preventive Medicine, College of Medicine, The Catholic University of Korea have published the research work: Seven Days of Bismuth-Based Quadruple Therapy Is as Effective for the First-Line Treatment of Clarithromycin-Resistant Confirmed Helicobacter pylori Infection as 14 Days of Bismuth-Based Quadruple Therapy, in the Journal: (JOURNAL)
• what: The 7-day BQT regimen was as effective as the 14-day BQT regimen for eradication of treatment-naïve clarithromycin-resistant confirmed H . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.